Belgium Sample Contracts

FOOTWORXX BE0628.836.152 (February 19th, 2021)
Meat-Tech 3D Ltd.AGREEMENT FOR THE SALE AND PURCHASE OF SHARES OF PEACE OF MEAT BV (February 18th, 2021)

Each hereafter referred to individually as a “Transferring Shareholder” and jointly as the “Transferring Shareholders”;

ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNION (February 12th, 2021)

This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:

GRANT AGREEMENT FOR AN ACTION WITH ONE BENEFICIARY (February 8th, 2021)

The European GNSS Agency (hereinafter referred to as the “GSA”), represented for the purposes of signature of this grant agreement by its Executive Director, Carlo DES DORIDES,

PLEASE READ CAREFULLY BEFORE INSTALLING: LICENCE AGREEMENT AND WARRANTY (February 3rd, 2021)

All products of ZEUS SOFT SPRL (company number BE0647962374) & H.M.S. SRL (company number IT02485350132) or any affiliates (collectively called "THE MANUFACTURER"), including evaluation packages, hardware, DVD/USB, protection keys and the user manual (collectively called the "Product") and all future orders, are subject to the terms stated below. BY INSTALLING THE PRODUCT, YOU ACKNOWLEDGE THAT YOU HAVE READ THIS DOCUMENT, UNDERSTAND IT, AND AGREE TO BE BOUND BY ITS TERMS AND CONDITIONS (collectively

ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNION (February 2nd, 2021)

This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:

D1.2 CONSORTIUM AGREEMENT‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌‌ (February 1st, 2021)

Project Acronym:‌ DiDIY Project Name Digital Do It Yourself Grant Agreement no. 644344 Start date of the project‌ 01/01/2015 End date of the project 30/06/2017 Work Package producing the document‌ WP1 - Project Management WP Lead Partner LIUC Other Partner(s) involved‌‌ all Deliverable identifier D1.2 Deliverable lead beneficiary LIUC Due date‌ M2 (February 2015) Date of delivery‌ 28/02/2015 Version 1.0 Author(s) LIUC Classification‌ CONFIDENTIAL Document Status‌ APPROVED This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 644344.‌‌‌‌ Disclaimer: The views expressed in this document do not necessarily reflect the views of the EC.‌‌

Grant agreement no: 612789 (January 31st, 2021)

RICHES is a collaborative project within the framework of the FP7 SSH Programme, funded by the EC, Grant Agreement 612789, and aimed at researching the context of change in which European CH is transmitted and the frameworks to be put in place for benefiting from CH in Europe in the digital age;

ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNION (January 29th, 2021)

This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:

EUROnu CONSORTIUM AGREEMENT 29th October 2008 SUBJECT TO CONTRACT (January 28th, 2021)

THIS CONSORTIUM AGREEMENT is based on REGULATION (EC) No 1906/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 December 2006 laying down the rules for the participation of undertakings, research centres and universities in actions under the Seventh Framework Programme and for the dissemination of research results (2007-2013) (“Rules for Participation”) and the EC Grant Agreement, adopted on 1st September 2008 (“the Grant Agreement”) and Annex II adopted on 1st September 2008 (“Annex II of the Grant Agreement”) and is made on 1st September 2008, (the “Effective Date”).

Terms and Conditions - Able (January 28th, 2021)

THIS AGREEMENT IS A LEGAL AND ENFORCEABLE CONTRACT BETWEEN ABLE NV, YOURSELF AND/OR YOUR COMPANY. YOUR ACCESS AND USE OF THE SERVICES, WHETHER PURCHASES DIRECTLY FROM ABLE NV OR THROUGH ONE OF ITS AUTHORISED RESELLERS OR DISTRIBUTORS, IS CONDITIONED ON YOUR ACCEPTANCE OF AND COMPLIANCE WITH THE FOLLOWING TERMS. THESE TERMS APPLY TO ALL VISITORS, AUTHORISED USERS AND OTHERS WHO ACCESS OR USE THE SERVICES.

END-USER LICENSE AGREEMENT(EULA) (January 27th, 2021)

This VECMAP® software end-user license agreement (the "Agreement") provides the terms and conditions under which Avia-GIS NV, with registered office at Risschotlei 33, 2980 Zoersel, Belgium (“Avia-GIS”) is willing to grant you (meaning the entity to which the person installing and/or using the Software belongs for the purposes of its use of the Software) (the "Licensee") a limited right to use the Software.

General Model Grant Agreement (January 27th, 2021)

This document is aimed at assisting applicants. It shows the full range of provisions that may be applied to this type of agreement, and is provided for information purposes only. The legally binding agreement will be that which is signed by the parties in the system.

Letter of Access Agreement for 2014 registrations of Silicon, FeSi Alloys, Silica Fume and Si/FeSi silicate under REACH Regulation 1907/2006 (Copyright Euroalliages AISBL-2010-Brussels) (January 25th, 2021)

(address of the Lead registrant), a Lead Company of the “Si” Consortium acting for purposes of this Agreement as Lead Registrant and on behalf of all Members of the Substance Information Exchange Forum for the substance [Silicon] (hereinafter referred to as "Lead Registrant"); hereby duly represented by EUROALLIAGES AISBL, Avenue de Broqueville 12, 1150 Brussels, by virtue of a written proxy,

CLINICAL TRIAL AGREEMENT – NON-COMMERCIAL RETROSPECTIVE STUDY NON ZOL SPONSORED (January 21st, 2021)

This Agreement may only be used as a model for a non-interventional retrospective study in which the past is studied on the basis of information that is already available at the start of the study.

Acronym of the Project Consortium Agreement, version ……., YYYY-MM-DD (January 20th, 2021)

REGULATION (EC) No 1906/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 December 2006 laying down the rules for the participation of undertakings, research centres and universities in actions under the Seventh Framework Programme and for the dissemination of research results (2007-2013) hereinafter referred to as Rules for Participation and the European Commission Grant Agreement, adopted on 10 April 2007, hereinafter referred to as the Grant Agreement or EC-GA and Annex II adopted on 10 April 2007, hereinafter referred to as Annex II of the EC-GA, and is made on YYYY-MM-DD, hereinafter referred to as “Effective Date”

CLINICAL TRIAL AGREEMENT – NON-COMMERCIAL NON-RETROSPECTIVE STUDY NON ZOL SPONSORED (January 18th, 2021)

………………………., with registered office at ……………………………, and registered with the Legal Entities Register under the business registration number ……………………..hereby represented by ………………………………………………………………..

FTK Consortium Agreement, version 1, 2013-03-04 (January 17th, 2021)

REGULATION (EC) No 1906/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 December 2006 laying down the rules for the participation of undertakings, research centres and universities in actions under the Seventh Framework Programme and for the dissemination of research results (2007-2013) hereinafter referred to as Rules for Participation and the European Commission Grant Agreement, adopted on 10 April 2007, hereinafter referred to as the Grant Agreement or EC-GA and Annex II adopted on 10 April 2007 Version 6 adopted on 24 January 2011, hereinafter referred to as Annex II of the EC-GA, and is made on 2013-03-11, hereinafter referred to as “Effective Date”

EOSC Portal Collaboration Agreement between (January 17th, 2021)

● The beneficiaries of the Complementary Grant Agreement N. 777536 (Acronym: EOSC-hub, Full title: Integrating and Managing Services for the European Open Science Cloud) hereinafter the "EOSC-hub", represented by STICHTING EGI (EGI Foundation), established in SCIENCE PARK 140, AMSTERDAM 1098 XG, Netherlands (the EOSC-hub Coordinator), represented for the purposes of signing the Agreement by its Managing Director, Yannick LEGRÉ.

CONFIDENTIAL DISCLOSURE AGREEMENT (TWO WAY) (January 15th, 2021)

THIS CONFIDENTIAL DISCLOSURE AGREEMENT (this “Agreement”) is made and entered into as of the 11. January 2021 (the “Effective Date”), by and between:

IMEC-Customer Agreement for access to TSMC technology (0.25µ, 0.18µ, 0.13µ and 90nm) (January 14th, 2021)

Interuniversitair Micro-Electronica Centrum vzw (IMEC), with its registered office at Kapeldreef 75, 3001 Leuven, Belgium, Register of Legal Entities Leuven VAT BE 0425.260.668, represented by Steve Beckers, Vice President

FTK Consortium Agreement, version 1, 2013-03-04 (January 14th, 2021)

REGULATION (EC) No 1906/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 December 2006 laying down the rules for the participation of undertakings, research centres and universities in actions under the Seventh Framework Programme and for the dissemination of research results (2007-2013) hereinafter referred to as Rules for Participation and the European Commission Grant Agreement, adopted on 10 April 2007, hereinafter referred to as the Grant Agreement or EC-GA and Annex II adopted on 10 April 2007 Version 6 adopted on 24 January 2011, hereinafter referred to as Annex II of the EC-GA, and is made on 2013-03-1104, hereinafter referred to as “Effective Date”

CLINICAL TRIAL AGREEMENT – NON COMMERCIAL NON-RETROSPECTIVE STUDY – MONOCENTRIC ZOL SPONSORED (January 14th, 2021)

Ziekenhuis Oost-Limburg, with registered office at 3600 Genk, Schiepse Bos 6, and registered with the Legal Entities Register under the business registration number 0256.543.917 hereby represented by its chairman, Mr. Tom Arts, its managing director, Mr. Erwin Bormans and its medical director, Dr. Griet Vander Velpen

CLINICAL TRIAL AGREEMENT – NON-COMMERCIAL NON-RETROSPECTIVE STUDY NON ZOL SPONSORED (January 14th, 2021)

………………………., with registered office at ……………………………, and registered with the Legal Entities Register under the business registration number ……………………..hereby represented by ………………………………………………………………..

CLINICAL TRIAL AGREEMENT – NON COMMERCIAL RETROSPECTIVE STUDY – MULTICENTRIC ZOL SPONSORED (January 8th, 2021)

This Agreement may only be used as a model for a non-interventional retrospective study in which the past is studied on the basis of information that is already available at the start of the study.

Model Substances Information Exchange Forum Agreement (SIEF Agreement) according to REACH Regulation (EC) No 1907/20061 (January 7th, 2021)

This upgraded version is only aimed at improving the wording of future SIEF agreements. Therefore, in regard to the SIEF agreements that have been agreed in the past and that are presently in place, no amendment is required.

Odoo Partnership Agreement (January 4th, 2021)

Odoo S.A., having its registered oWce at Chaussée de Namur, 40, 1367 Grand-Rosière, Belgium, and its aWliates (collectively referred to as “ODOO”)

Contract (January 1st, 2021)
OF THE ONE PART, (December 31st, 2020)

Contracting Parties to the Treaty on European Union and the Treaty on the Functioning of the European Union, hereinafter referred to as the 'Member States',

Meat-Tech 3D Ltd.AGREEMENT FOR THE SALE AND PURCHASE OF SHARES OF PEACE OF MEAT BV (December 31st, 2020)

Each hereafter referred to individually as a “Transferring Shareholder” and jointly as the “Transferring Shareholders”;

General Terms and Conditions VENN (December 29th, 2020)
PLEASE READ THIS DOCUMENT CAREFULLY BEFORE AGREEING TO ITS CONTENTS. BY CHECKING THE ACCEPTANCE BOX ON YOUR SCREEN, AND/OR BY DOWNLOADING, INSTALLING AND USING THE SOFTWARE, YOU CONFIRM YOUR AGREEMENT TO BE BOUND BY THE TERMS OF THIS AGREEMENT. IF YOU DO ... (December 23rd, 2020)

This document (hereafter referred to as the “Agreement”) constitutes an agreement entered into by and between you and Altsoft nv (hereafter referred to as “Altsoft”), a corporation under Belgian law with its registered offices at Drabstraat 28, 2640 Mortsel, Belgium, under the company number BE0474378894.

CLINICAL TRIAL AGREEMENT – COMMERCIAL NON-RETROSPECTIVE STUDY (December 21st, 2020)

………………………., with registered office at ……………………………, and registered with the Legal Entities Register under the business registration number ……………………..hereby represented by ………………………………………………………………..

Agreement between Cefic and the Company to be SQAS/ESAD Assessed Company (December 16th, 2020)

This agreement is made between Cefic, with their office in Brussels and the Company to be SQAS/ESAD Assessed (“Assessed Company”) named below.

Cooperation Agreement (December 15th, 2020)

Hereafter referred to individually as a “Party” or collectively as the “Parties” for the purpose of establishing the cooperation arrangements between the Parties relating to the European Youth Capital 2024 (hereinafter referred to the "EYC 2024").